US 9630929
Benzenesulfonamide compounds and their use as therapeutic agents
granted A61PA61P11/00A61P17/04
Quick answer
US patent 9630929 (Benzenesulfonamide compounds and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P11/00, A61P17/04, A61P19/00, A61P19/02